Impact Factor
4.67
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
23.26
5,400 total citations
h5-index
100
h5 depth signal
Cited share
75.8%
191 of 252
Total citations
5,400
Citation footprint
Metric signal
21.06
External metric anchor
Self-citation
1.1%
61 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
490
United Kingdom
141
Germany
139
Australia
116
Netherlands
104
Citing Fields of Research
Kidney Diseases
824
Urology
296
Immunology
162
Transplantation
125
Diabetes
98
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,229
Articles tracked across the journal lifetime
Indexed publication set
252
191 cited publications
Last 12 months
125
10.4 publications/month
Open access share
4.8%
6 OA publications in the last year
Leading citing country
United States
490 citing publications
Leading citing field
Kidney Diseases
824 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v5n4, Apr. 2009-
v5n4, Apr. 2009-
Research Focus & Classification
Indexed Subjects
Kidney Diseases
Broad Categories
Nephrology
Urology
MeSH Descriptors
Kidney Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1038/s41581-026-01136-3
Open DOI
Closing the gap: disparities in access to and implementation of guideline-directed medical therapy for CKM syndrome
02
DOI 10.1038/s41581-026-01138-1
Open DOI
Infection-associated acute kidney injury in resource-limited settings
Acute kidney injury (AKI) is a frequent and life-threatening complication of infection, and a major contributor to preventable morbidity and mortality in resource-limited settings. In these contexts, AKI is commonly driven by a broad ran...
03
DOI 10.1038/s41581-026-01142-5
Open DOI
Cardiovascular–kidney–metabolic syndrome and cancer
04
DOI 10.1038/s41581-026-01137-2
Open DOI
The case for cardiovascular–kidney–liver–metabolic syndrome
05
DOI 10.1038/s41581-026-01141-6
Open DOI
Sex and gender in cardiovascular–kidney–metabolic health: strengthening the evidence
06
DOI 10.1038/s41581-026-01140-7
Open DOI
Preventative nephrology in the cardiovascular–kidney–metabolic era
07
DOI 10.1038/s41581-026-01111-y
Open DOI
Metabolic control by liver–kidney crosstalk and glucagon in health and disease
08
DOI 10.1038/s41581-026-01125-6
Open DOI
Targeting the aldosterone–mineralocorticoid receptor pathway in cardiovascular–kidney–metabolic syndrome
The concept of cardiovascular–kidney–metabolic (CKM) syndrome integrates cardiovascular, kidney and metabolic disorders into a single pathophysiological continuum characterized by chronic inflammation, oxidative stress, fibrosis and prog...
09
DOI 10.1038/s41581-026-01128-3
Open DOI
Recommendations for the management of frailty in chronic kidney disease: a consensus report
Frailty is highly prevalent in patients with chronic kidney disease (CKD) and is associated with increased mortality, hospitalization and disability and with poorer quality of life. Despite its prognostic importance, substantial knowledg...
10
DOI 10.1038/s41581-026-01127-4
Open DOI
Cardiovascular–kidney–metabolic syndrome as a mitochondrial systems disorder
Cardiovascular–kidney–metabolic (CKM) syndrome is a multisystem disorder in which obesity, diabetes, chronic kidney disease, and cardiovascular disease reinforce one another through shared pathobiological characteristics and bidirectiona...
Bibliographical & Catalog Notes
Description based on: Vol. 5, no. 4 (Apr. 2009); title from cover.
Latest issue consulted: Vol. 5, no. 4 (Apr. 2009).
Also issued online.